TEST:

Immunoscore® IC Assay

.@KristenCiombor @VUMCHemOnc on IO in MSI-H met #colorectalcancer - need to test (!) to find & figure out why some don’t respond: non-Lynch? KRASmt? Higher ECOG PS from symptom burden, maybe they need doublet? Need better biomarkers, hopefully Immunoscore IC! #WCGIC2023 @WCGIC (@benweinbergmd)

Excellent presentation by Carlotta Antonietti @ChiaraCrem1 on the Atezo-Tribe. Immunoscore IC may help identify patients with pMMR mCRC who benefit from IO. #ASCO23 (@MyriamChalabi)

CRC oral session on the updated and OS results of the AtezoTRIBE study by GONO. Again confirmation that Immunoscore IC is able to select patients with immunesensitive pMMR/MSS mCRC and PFS/OS benefit from the addition of atezo to FOLFOXIRI/bev. @carlottanto1 @ChiaraCrem1 (@FoundationGono)

New translational analysis of AtezoTRIBE study by @FoundationGono. Immunoscore IC does not overlap with TILs and shows the best predictive ability re efficacy of adding Atezo in pMMR mCRC @FilippoPietran4 (@ChiaraCrem1)

New data on the usefulness of #Immunoscore IC as an immune biomarker in metastatic #NSCLC and #CRC to be presented by Dr. @JeromeGalon at the 5th Annual @marketsmarkets Next Gen Immuno-Oncology Conference, Friday June 24, 2022, 11:15 - 11:45 a.m. EDT ()